Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on May 16, 2016
At Pfizer Oncology, a key technology focus is advancing the next wave of antibody drug conjugates, which are targeted therapies that combine the specificity of an antibody with the cancer cell–killing power of a chemotherapy.